A business in context

BHIC research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001096906-26-001173

  2. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001185185-26-001775

  3. 8-K · Current report

    Report date 2026-04-02 · 0001185185-26-001231 · Items 5.02

  4. 10-K · Annual report

    Report date 2025-12-31 · 0001185185-26-001133

  5. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001185185-25-001545

  6. 8-K · Current report

    Report date 2025-09-10 · 0001185185-25-001456 · Items 5.03,5.07,9.01

  7. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001185185-25-000908

  8. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001185185-25-000413

  9. 8-K · Current report

    Report date 2025-03-14 · 0001185185-25-000186 · Items 5.03

  10. 10-K · Annual report

    Report date 2024-12-31 · 0001185185-25-000176

  11. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001185185-24-001038

  12. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001185185-24-000738

  13. 8-K/A · Current report

    Report date 2023-03-10 · 0001185185-24-000654 · Items 1.01,2.01,3.02,5.02,5.06,9.01

  14. 8-K · Current report

    Report date 2024-05-22 · 0001185185-24-000582 · Items 4.01,9.01

  15. 10-Q · Quarterly report

    Report date 2023-02-28 · 0001185185-24-000542

  16. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001185185-24-000468

  17. 10-K · Annual report

    Report date 2023-12-31 · 0001185185-24-000327

  18. 10-Q · Quarterly report

    Report date 2023-09-30 · 0001185185-23-001118

  19. 10-Q · Quarterly report

    Report date 2023-06-30 · 0001185185-23-000816

  20. 10-Q · Quarterly report

    Report date 2023-03-31 · 0001185185-23-000504

  21. 8-K · Current report

    Report date 2023-03-21 · 0001185185-23-000249 · Items 5.02

  22. 8-K · Current report

    Report date 2023-03-10 · 0001185185-23-000223 · Items 2.01,3.02,5.02,5.03,5.06

  23. 8-K · Current report

    Report date 2023-02-13 · 0001185185-23-000148 · Items 1.01,9.01

  24. 10-Q · Quarterly report

    Report date 2022-11-30 · 0001185185-23-000031

  25. 8-K · Current report

    Report date 2022-11-22 · 0001185185-22-001369 · Items 1.01,9.01

  26. 10-K · Annual report

    Report date 2022-08-31 · 0001185185-22-001245

  27. 10-Q · Quarterly report

    Report date 2022-05-31 · 0001185185-22-000817

  28. 10-Q · Quarterly report

    Report date 2022-02-28 · 0001185185-22-000443

  29. 10-Q · Quarterly report

    Report date 2021-11-30 · 0001185185-22-000063

  30. 10-K · Annual report

    Report date 2021-08-31 · 0001185185-21-001761

  31. 8-K · Current report

    Report date 2021-04-02 · 0001185185-21-001231 · Items 5.01,5.02

  32. 10-Q · Quarterly report

    Report date 2021-05-31 · 0001683168-21-002978

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001784440BioScience Health Innovations, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • Nowtransit Inc · former SEC name · 2019-11-04 to 2025-03-13

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$1.84M$1.96M
2023-12-31$597.6K$654.9K
2022-12-31$69.3K$79.1K
2022-08-31$0$0
2021-08-31$0$0
2020-08-31$0$0

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗